Your super is working hard to give you the retirement you deserve, but it’s also helping to deliver groundbreaking technology that improves our health.
Our investment in Nanopore Technologies is helping to revolutionise DNA and RNA sequencing. The UK company makes products that deliver real-time genetic analysis, including handheld devices that scientists can use anywhere – the lab, the field and even in space.
The products have almost endless applications and are making a big impact in healthcare, food safety and security and environmental management and conservation.
Nanopore Technologies also played a role in combatting COVID-19. At March 2021, around a quarter of the COVID-19 sequences in the global genomic database of influenza virus platform, GISAID, were sequenced on a Nanopore device.
Our investment in Nanopore Technologies is just one example of our $3 billion investment in projects that aim to change the world for the better while delivering future investment returns for our members.
See more on how we invest your money.